Blog

Why Medicare Is Right To Negotiate Drug Prices

The Biden Administration has announced its list of the first 10 drugs that will be subject to price negotiations, a step allowed for the first time when Congress passed last year’s Inflation Reduction Act. The Pharmaceutical Manufacturers’ Association (PhRMA), the main drugmaker lobby, blasted the law. No surprise there. But its reasoning is evidence of how perverse the US health [...]

By |2023-08-30T11:36:35-04:00August 30th, 2023|Medicare|0 Comments

For The First Time, Traditional Medicare Will Pay To Support Family Caregivers

The federal agency that operates Medicare, the Centers for Medicare and Medicaid Services (CMS), is finally recognizing what families have known for, well, thousands of years:  Family members are the bedrock of the system of care for frail older adults and younger people with disabilities. And the agency is taking some important steps to help them. Some proposals will provide [...]

By |2023-08-23T11:35:50-04:00August 23rd, 2023|family caregivers, Medicare, Uncategorized|0 Comments

Why Do So Few Doctors Want To Specialize In Caring For Older Adults?

You might think that the aging of the Baby Boom generation, with the Gen Xers following close behind, would make geriatric medicine a popular specialty. Almost as attractive, perhaps, as orthopedic surgery. But you’d be very, very wrong. In 2000, there were only about 10,000 board-certified geriatricians to care for 35 million Americans age 65 or older.  That was bad [...]

By |2023-08-15T10:56:51-04:00August 15th, 2023|Health Care|0 Comments

Should People With No Symptoms Get A Diagnosis of Alzheimer’s Disease?

The National Institute on Aging and the Alzheimer’s Association have proposed revised clinical guidelines that would designate seven major stages of the brain disease. The first two would be for people who have no symptoms but may be at higher risk for Alzheimer’s. These technical guidelines, which would update a 2018 version, could have enormous, and conflicting, implications for drug [...]

By |2023-08-08T10:47:15-04:00August 8th, 2023|dementia|0 Comments

The Quiet Struggles Of Those Living Alone With Memory Loss

Living with memory loss and other cognitive limitations is hard. But when you can’t remember or can’t process information well enough to make important decisions, and you have no one by your side to support you, life can be extra tough. Researchers at the University of California San Francisco ((UCSF) estimate that about 4.3 million older adults with cognitive impairment [...]

By |2023-07-18T10:37:57-04:00July 18th, 2023|dementia, Uncategorized|0 Comments

Are Seniors More Likely To Enroll In Medicaid If States Expand Home-Based Long-Term Care?

While many states have expanded their Medicaid home and community-based services (HCBS) for frail older adults, others continue to steer many enrollees into nursing homes. One big reason: They fear that enhancing home supports will encourage more older adults to enroll in Medicaid long-term care services (LTSS) and increase state costs. But a new study published in the Journal of [...]

By |2023-07-10T11:36:41-04:00July 10th, 2023|Medicaid|0 Comments

FDA Has Approved The Anti-Alzheimer’s Drug Leqembi. What You Need To Know

The Food and Drug Administration (FDA) has granted final approval to the anti-Alzheimer’s drug lecanamab, marked as Leqembi by drugmakers Eisai and Biogen. Here is what you need to know: What does it do? In a formal phase 3 trial, Leqembi was shown to slow the progression of memory loss and cognitive impairment in patients with early-stage Alzheimer’s disease by [...]

By |2023-07-06T17:25:34-04:00July 6th, 2023|dementia, Uncategorized|0 Comments

Why Are Care Delivery Models For People With Dementia Developing So Slowly?

Enormous attention is being given to controversial drugs aimed at slowing the progression of early-stage Alzheimer’s disease. Yet, a very different set of clinical innovations holds the promise of helping far more people living with dementia and their families in more immediate—and perhaps more effective—ways. These care delivery models are aimed at breaking down the often-impenetrable barriers between health care [...]

By |2023-06-27T10:36:59-04:00June 27th, 2023|dementia, Uncategorized|0 Comments

Should State Long-Term Care Insurance Funds Invest In Stocks?

California’s evolving effort to build a public long-term care insurance program includes an important, and potentially far-reaching, feature: The insurance fund would be allowed to invest some assets in stocks. This would be a dramatic change for both social insurance and long-term care insurance. For example, Social Security is allowed to invest only in Treasury bonds. Regulators require private long-term [...]

By |2023-06-22T13:46:52-04:00June 22nd, 2023|long-term care insurance|0 Comments

The Biggest Barrier To New Anti-Alzheimer’s Drugs May Be Cost, Not Medicare Rules

The drug industry and its supporters are blasting the Centers for Medicare and Medicaid Services (CMS) for proposing to limit Medicare payments for the new anti-Alzheimer’s drug lecanemab to patients who participate in a trial or a special registry aimed at tracking their experience with the drug. CMS says the record-keeping will help provide important, real-world information about the benefits [...]

By |2023-06-14T12:12:06-04:00June 14th, 2023|dementia|0 Comments